Growing Revenue Stream PTC Therapeutics has achieved a substantial revenue range of 500 million to one billion dollars, indicating strong market presence and potential for expanding sales of pharmaceutical and support services.
Strategic Collaborations The company's partnership with Novartis for the development of PTC518 showcases opportunities to offer specialized research tools, technology solutions, or co-marketing services aligned with their pipeline development efforts.
Innovative Drug Development PTC is actively advancing its pipeline with drugs like PTC-518 in phase 2 trials, signaling ongoing needs for laboratory services, clinical trial support, and regulatory consulting to support drug progression.
Patient Support Expansion Recent launch of non-commercial pharmacy dispensing services and partnerships with RareMed Solutions highlight opportunities to provide patient engagement platforms, pharmacy management solutions, or patient data analytics to enhance therapy adherence.
Research and Data Tech Use The company's utilization of advanced analytics and visualization tools such as Power BI and Oracle Fusion indicates a potential market for data management, analytics software, and digital transformation services to optimize R&D and operational efficiency.
$1B$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$1B$10BPTC Therapeutics, Inc. uses 8 technology products and services including SAS/GRAPH, Power BI, Varnish, and more. Explore PTC Therapeutics, Inc.'s tech stack below.
| PTC Therapeutics, Inc. Email Formats | Percentage |
| FLast@ptcbio.com | 93% |
| FirstLast@ptcbio.com | 3% |
| First.Last@ptcbio.com | 3% |
| FMiddleLast@ptcbio.com | 1% |
Biotechnology ResearchNew Jersey, United States1001-5000 Employees
PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for children and adults living with rare and serious disease.
Company Overview
Media & News
Funding & FinancialsPTC Therapeutics, Inc. has raised a total of $1B of funding over 15 rounds. Their latest funding round was raised on Oct 27, 2022 in the amount of $1B.
PTC Therapeutics, Inc.'s revenue is estimated to be in the range of $500M$1B
Funding & FinancialsPTC Therapeutics, Inc. has raised a total of $1B of funding over 15 rounds. Their latest funding round was raised on Oct 27, 2022 in the amount of $1B.
PTC Therapeutics, Inc.'s revenue is estimated to be in the range of $500M$1B
1-888-653-2347 
support@leadiq.com